BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

980 related articles for article (PubMed ID: 33321093)

  • 21. Role of GPX4 in ferroptosis and its pharmacological implication.
    Seibt TM; Proneth B; Conrad M
    Free Radic Biol Med; 2019 Mar; 133():144-152. PubMed ID: 30219704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A guide to ferroptosis, the biological rust of cellular membranes.
    Veeckmans G; Van San E; Vanden Berghe T
    FEBS J; 2024 Jul; 291(13):2767-2783. PubMed ID: 37935445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging roles of ferroptosis in liver pathophysiology.
    Kim KM; Cho SS; Ki SH
    Arch Pharm Res; 2020 Oct; 43(10):985-996. PubMed ID: 33079307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT.
    Wang Z; Ding Y; Wang X; Lu S; Wang C; He C; Wang L; Piao M; Chi G; Luo Y; Ge P
    Cancer Lett; 2018 Aug; 428():21-33. PubMed ID: 29702192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boosting the Ferroptotic Antitumor Efficacy via Site-Specific Amplification of Tailored Lipid Peroxidation.
    An Y; Zhu J; Liu F; Deng J; Meng X; Liu G; Wu H; Fan A; Wang Z; Zhao Y
    ACS Appl Mater Interfaces; 2019 Aug; 11(33):29655-29666. PubMed ID: 31359759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of cytochrome P450 oxidoreductase enhances metabolism and DNA adduct formation of benzo[a]pyrene in Hepa1c1c7 cells.
    Reed L; Jarvis IWH; Phillips DH; Arlt VM
    Mutagenesis; 2019 Dec; 34(5-6):413-420. PubMed ID: 31612222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
    Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
    Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro.
    Homma T; Kobayashi S; Sato H; Fujii J
    Exp Cell Res; 2019 Nov; 384(1):111592. PubMed ID: 31479686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LPCAT1-mediated membrane phospholipid remodelling promotes ferroptosis evasion and tumour growth.
    Li Z; Hu Y; Zheng H; Li M; Liu Y; Feng R; Li X; Zhang S; Tang M; Yang M; Yu R; Xu Y; Liao X; Chen S; Qian W; Zhang Q; Tang D; Li B; Song L; Li J
    Nat Cell Biol; 2024 May; 26(5):811-824. PubMed ID: 38671262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulative mechanisms in NADH- and NADPH-supported N-oxidation of 4-chloroaniline catalyzed by cytochrome b5-enriched rabbit liver microsomal fractions.
    Golly I; Hlavica P
    Biochim Biophys Acta; 1987 Jun; 913(2):219-27. PubMed ID: 3109485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment.
    Kukiełka E; Dicker E; Cederbaum AI
    Arch Biochem Biophys; 1994 Mar; 309(2):377-86. PubMed ID: 8135551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms of ferroptosis and its role in cancer therapy.
    Xu T; Ding W; Ji X; Ao X; Liu Y; Yu W; Wang J
    J Cell Mol Med; 2019 Aug; 23(8):4900-4912. PubMed ID: 31232522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Participation of superoxide, hydrogen peroxide and hydroxyl radicals in NADPH-cytochrome P-450 reductase-catalyzed peroxidation of methyl linolenate.
    Kameda K; Ono T; Imai Y
    Biochim Biophys Acta; 1979 Jan; 572(1):77-82. PubMed ID: 32915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ferroptosis as an emerging target in inflammatory diseases.
    Mao H; Zhao Y; Li H; Lei L
    Prog Biophys Mol Biol; 2020 Sep; 155():20-28. PubMed ID: 32311424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monooxygenase system in Guerin’s carcinoma of rats under conditions of ω-3 polyunsaturated fatty acids administration.
    Marchenko MM; Ketsa OV; Shmarakov IO; Abutnaritsa KH
    Ukr Biochem J; 2016; 88(4):48-56. PubMed ID: 29235764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting ferroptosis in rhabdomyosarcoma cells.
    Dächert J; Ehrenfeld V; Habermann K; Dolgikh N; Fulda S
    Int J Cancer; 2020 Jan; 146(2):510-520. PubMed ID: 31173656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FAF1 blocks ferroptosis by inhibiting peroxidation of polyunsaturated fatty acids.
    Cui S; Simmons G; Vale G; Deng Y; Kim J; Kim H; Zhang R; McDonald JG; Ye J
    Proc Natl Acad Sci U S A; 2022 Apr; 119(17):e2107189119. PubMed ID: 35467977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochrome P450 IIIA1 (P450p) requires cytochrome b5 and phospholipid with unsaturated fatty acids.
    Eberhart DC; Parkinson A
    Arch Biochem Biophys; 1991 Dec; 291(2):231-40. PubMed ID: 1659320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis.
    Hu Z; Zhang H; Yi B; Yang S; Liu J; Hu J; Wang J; Cao K; Zhang W
    Cell Death Dis; 2020 Jan; 11(1):73. PubMed ID: 31996668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity.
    Xie Y; Zhu S; Song X; Sun X; Fan Y; Liu J; Zhong M; Yuan H; Zhang L; Billiar TR; Lotze MT; Zeh HJ; Kang R; Kroemer G; Tang D
    Cell Rep; 2017 Aug; 20(7):1692-1704. PubMed ID: 28813679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.